Pacira BioSciences (PCRX) Asset Utilization Ratio (2011 - 2026)
Pacira BioSciences (PCRX) posted quarterly Asset Utilization Ratio of 0.59 for Q1 2026, up 32.75% year-over-year from 0.45 in Q1 2025, and up 4.81% quarter-over-quarter from 0.57 in Q4 2025.
Pacira BioSciences (PCRX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Pacira BioSciences' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.59 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 32.75% year-over-year to 0.59; the TTM figure through Mar 2026 stood at 0.59 (up 32.75% YoY), while the FY2025 annual figure was 0.52, up 15.01% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.59, up from 0.57 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.59 in Q1 2026, with the low at 0.0 in Q3 2023.
- The 5-year median for Asset Utilization Ratio is 0.43 (2024), against an average of 0.34.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio slumped 99.73% in 2023, then jumped 43749.98% in 2024.
- Pacira BioSciences' Asset Utilization Ratio stood at 0.0 in 2022, then soared by 27643.02% to 0.43 in 2023, then advanced by 4.99% to 0.46 in 2024, then rose by 24.36% to 0.57 in 2025, then increased by 4.81% to 0.59 in 2026.
- Business Quant data shows PCRX's Asset Utilization Ratio at 0.59 in Q1 2026, 0.57 in Q4 2025, and 0.51 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Pacira BioSciences | 946.10 Mn | 695.07 Mn | 148.24 Mn | 0.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.61 |
| Mar 31, 2026 | 0.59 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.45 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.46 |
| Sep 30, 2024 | 0.44 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 0.43 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.38 |